VEON vs PHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 28, 2026

VEON

51.2
AI Score
VS
VEON Wins

PHI

48.3
AI Score

Investment Advisor Scores

VEON

51score
Recommendation
HOLD

PHI

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric VEON PHI Winner
Forward P/E 7.6628 7.716 VEON
PEG Ratio 2.2274 2.6603 VEON
Revenue Growth 17.1% 2.2% VEON
Earnings Growth 1.6% -1.7% VEON
Tradestie Score 51.2/100 48.3/100 VEON
Profit Margin 11.6% 13.6% PHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

VEON 1M: +2.2% · 3M: +5.6% PHI 1M: +10.2% · 3M: -0.6%

Current Technical Phase

VEON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.5 · Price: $53.12

PHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.5 · Price: $19.78

Fundamentals Snapshot

Metric VEON PHI
Market Cap
Forward P/E 6.4 7.4
Trailing P/E 52.3 9.2
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.9% 0.7%
Operating Margin 0.3% 0.2%
EPS 1.00 2.14
Dividend Yield 0.08%

Frequently Asked Questions

Based on our detailed analysis, VEON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.